阿昔莫司在降低脂蛋白a 方面的临床研究
摘要
阿昔莫司的治疗效果明显优于阿托伐他汀。
关键词
全文:
PDF参考
[1]Cannon, C. P. et al.Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes[J].The New England journal of medicine
,2015(372):2387–2397.
[2]Ellis, K. L., Boffa, M. B., Sahebkar, A., Koschinsky, M. L. & Watts, G. F.The renaissance of lipoprotein(a):Brave new world for
preventive cardiology?[J].Progress in Lipid Research,2017(68):57–82.
[3]Pirro, M. et al.Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity[J]. Pharmacological
Research,2017(119):178–187.
[4]Marcovina, S. M., Albers, J. J.Lipoprotein (a) measurements for clinical application[J].Journal of Lipid
Research,2015,57(4):526–537.
[5]Schmidt, K., Noureen, A., Kronenberg, F. Utermann, G.Structure, function, and genetics of lipoprotein (a)[J]Lipid
Res,2016(57):1339–1359.
[6]Thomas, T. et al.CETP (Cholesteryl Ester Transfer Protein) Inhibition With Anacetrapib Decreases Production of Lipoprotein(a)
in Mildly Hypercholesterolemic Subjects[J].Arteriosclerosis, thrombosis, and vascular biology,2017(37):1770–1775.
[7]Sharma, M., Redpath, G. M., Williams, M. J. McCormick, S. P.Recycling of Apolipoprotein(a) After PlgRKT-Mediated
Endocytosis of Lipoprotein(a) [J].Circulation research,2017(120):1091–1102.
[8]Tie, C. et al.Ezetimibe Attenuates Atherosclerosis Associated with Lipid Reduction and Inflammation Inhibition[J].PLOS
ONE,2015,10(11):142-430.
[9]Qin, L. et al.Anti-inflammatory activity of ezetimibe by regulating NF-kappaB/MAPK pathway in THP-1 macrophages[J].
Pharmacology,2014(93):69–75.
[10]Dolezelova, E. et al.Effect of ezetimibe on plasma adipokines: a systematic review and meta-analysis[J].Br J Clin
Pharmacol,2017(83):1380–1396.
[11]Tsimikas, S.A Test in Context: Lipoprotein(a)[J].Journal of the American College of Cardiology,2017,69(6):692–711.
DOI: http://dx.doi.org/10.18686/xjjz.v2i2.26015
Refbacks
- 当前没有refback。